Influence of Repeated Cut-off and Rescanning on the Trueness of the Intraoral Digital Scans.

OBJECTIVES: To evaluate the effects of repeated cut-off and rescan procedures on the trueness of three intraoral scanners (IOS). METHODS: A tooth model (#16) with a standard class II cavity was prepared, and the complete-arch was scanned using a laboratory scanner (D2000, 3Shape A/S) to obtain a reference scan. Then the typodont was scanned with three IOSs (3Shape TRIOS 3, CEREC Omnicam, and Medit i500) under two rescanning strategies (full-cut and partial-cut), with varying numbers of repeated cut-off and rescanning procedures (0, 1, 3, 5, 7, or 10). The trueness discrepancy between the reference and experimental digital scan was estimated using root mean square (RMS) calculations. Three regions of interest were selected to represent the rescanning, identification, and non-rescan area. And the discrepancies were analyzed using a linear mixed model (α=.05). RESULTS: Cut-off and rescanning procedures significantly decreased the trueness of digital scans in all test conditions compared to the reference. However, no progressive increase in discrepancy was observed under any rescan conditions. Significant influences on trueness were found based on the IOS used, with the 3Shape system exhibiting lower RMS values. The partial-cut strategy showed lower RMS values compared to the full-cut strategy, albeit without statistical significance. CONCLUSIONS: While repeated cut-off and rescanning procedures led to a decline in the quality of digital impressions, they did not result in discrepancy accumulation with repeated rescanning. CLINICAL SIGNIFICANCE: To ensure high scanning accuracy in dental practice, it is advisable to minimize the rescanning area when correcting imperfections in digital scans. Additionally, selecting an appropriate scanner can help mitigate the negative effects of the rescanning technique.

Effect of a Novel 'Scan Body' on the In Vitro Scanning Accuracy of Full-Arch Implant Impressions.

OBJECTIVE: This in vitro study aimed to determine whether a newly designed arcuate scan body can improve intraoral scanning accuracy for implant rehabilitation of edentulous jaws. MATERIAL AND METHODS: A master model containing 4 implant abutment replicas was fabricated and digitized with different scan bodies using an intraoral scanner. Four types of scan bodies were evaluated: original scan bodies (group OS), computer-aided design and computer-aided manufacturing (CAD/CAM) scan bodies without extension (group CS), CAD/CAM scan bodies with straight extension (group CSS), and CAD/CAM scan bodies with arcuate extension (group CSA). Conventional splinted open-tray impressions (group CI) were used as controls. The master model and the poured casts were digitized using a laboratory scanner. Impressions were repeated 10 times each in 5 groups. Scans in standard tessellation language format were exported to reverse engineering software and root mean square (RMS) values were used for trueness and precision assessments. In each group, 45 RMS values were acquired for precision evaluation and 10 RMS values were obtained for trueness assessment. Statistical evaluation was performed with the Kruskal-Wallis test and Dunn-Bonferroni test (α = 0.05). RESULTS: The median trueness values were 41.40, 55.95, 39.80, 39.75, and 22.30 µm for group OS, CS, CSS, CSA, and CI, respectively. CI showed better trueness than OS (P = .020), CS (P < .001), and CSS (P = .035). The median precisions for group OS, CS, CSS, CSA, and CI were 47.40, 51.50, 43.90, 25.20, and 24.60 µm. respectively. The precision of CSA and CI were higher than OS (P < .001), CS (P < .001), and CSS (P < .001). Between CI and CSA, there was no significant difference (P = 1.000). CONCLUSIONS: For full-arch implant rehabilitation, the scan body with arcuate extension could improve the intraoral scanning precision and showed similar 3-dimensional discrepancy compared to conventional splinted open-tray impressions.

Injectable ultrasound-powered bone-adhesive nanocomposite hydrogel for electrically accelerated irregular bone defect healing.

The treatment of critical-size bone defects with irregular shapes remains a major challenge in the field of orthopedics. Bone implants with adaptability to complex morphological bone defects, bone-adhesive properties, and potent osteogenic capacity are necessary. Here, a shape-adaptive, highly bone-adhesive, and ultrasound-powered injectable nanocomposite hydrogel is developed via dynamic covalent crosslinking of amine-modified piezoelectric nanoparticles and biopolymer hydrogel networks for electrically accelerated bone healing. Depending on the inorganic-organic interaction between the amino-modified piezoelectric nanoparticles and the bio-adhesive hydrogel network, the bone adhesive strength of the prepared hydrogel exhibited an approximately 3-fold increase. In response to ultrasound radiation, the nanocomposite hydrogel could generate a controllable electrical output (-41.16 to 61.82 mV) to enhance the osteogenic effect in vitro and in vivo significantly. Rat critical-size calvarial defect repair validates accelerated bone healing. In addition, bioinformatics analysis reveals that the ultrasound-responsive nanocomposite hydrogel enhanced the osteogenic differentiation of bone mesenchymal stem cells by increasing calcium ion influx and up-regulating the PI3K/AKT and MEK/ERK signaling pathways. Overall, the present work reveals a novel wireless ultrasound-powered bone-adhesive nanocomposite hydrogel that broadens the therapeutic horizons for irregular bone defects.

Prognostic and clinicopathological value of m6A regulators in human cancers: a meta-analysis.

BACKGROUND: N6-methyladenosine (m6A) is the most abundant epigenetic modification. Although the dysregulation of m6A regulators has been associated with cancer progression in several studies, its relationship with cancer prognosis and clinicopathology is still controversial. Therefore, we evaluated the prognostic and clinicopathological value of m6A regulators in cancers by performing a comprehensive meta-analysis. METHODS: The PubMed, Cochrane Library, Web of Science, and Embase databases were searched up to April 2022. Hazard ratios were used to analyze the association between m6A with prognosis. We also analyze the relationship between m6A and clinicopathology using odds ratios. RESULTS: METTL3 overexpression predicted poor overall survival and disease-free survival in cancer patients (p < 0.001) such as gastric cancer (p < 0.001), esophageal squamous cell carcinoma (p < 0.001), oral squamous cell carcinoma (p = 0.002) and so on. Additionally, METTL3 overexpression was associated with poor pT stage (p < 0.001), pN stage (p < 0.001), TNM stage (p < 0.001), tumor size >5 cm (p < 0.001) and vascular invasion (p = 0.024). Conversely, METTL14 overexpression was positively associated with better OS (p < 0.001), negatively with poor pT stage (p = 0.001), pM stage (p = 0.002), pN stage (p = 0.011) and TNM stage (p < 0.001). Moreover, KIAA1429 overexpression was associated with poor OS (p = 0.001). YTHDF1 overexpression was also associated with advanced pM stage (p < 0.001) and tumor size >5 cm (p < 0.001). However, ALKBH5 overexpression was negatively associated with vascular invasion (p = 0.032). CONCLUSIONS: High expression of METTL3 predicted poor outcome. In contrast, high expression of METTL14 was associated with better outcome. Thus, we suggest that among all the m6A regulators, METTL3 and METTL14 could be potential prognostic markers in cancers.